Your browser doesn't support javascript.
loading
Analysis of predisposing factors and drug resistance of urinary tract infection with extended-spectrum beta-lactamase producing Escherichia Coli / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy ; (12): 554-555, 2008.
Artículo en Chino | WPRIM | ID: wpr-400989
ABSTRACT
Objective To investigate the predisposing factors of urinary tract infection(UTI) with extendedspectrum beta-lactaraase(ESBLs) producing Escherichia Coli(E. coli) and its resistance to antimicrobial agents.Methods 26 cases of UTI patients with ESBLs producing E. coli from 2003 to 2005 in our hospital were analyzed retrospectively and compared with the ESBLs non-producing strains. Results 88.5 % of the patients with UTI in ESBLs producing E. coli had received broad-spectrum antimierobial therapy before the diagnosis, 69.2 % of the patients were complicate UTIS, 42.3 % of the patients experienced invasive operations in urinary tract; the incidence of drug resistance of ESBLs producing bacteria to the second, third-generation cephalosporins and quinolone was significantly higher than that of ESBLs non-producing bacteria, but it was highly sensitive to imipenem. Conclusion The drug resistance of ESBLs producing E. coli is severe gradually. So much attention should be paid to the ESBLs producing bacteria detection in UTIs. Antimicrobial therapy should be initiated under the guidance of drug sensitivity test,it is necessary to rid the predisposing factors of UITs as much as possible in order to decrease ESBLs-producing bacteria infection.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Guía de Práctica Clínica Idioma: Chino Revista: Chinese Journal of Primary Medicine and Pharmacy Año: 2008 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Guía de Práctica Clínica Idioma: Chino Revista: Chinese Journal of Primary Medicine and Pharmacy Año: 2008 Tipo del documento: Artículo